Yahoo Web Search

  1. Yahoo Finance Results

  2. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices ...

  3. Hologic, Inc. HOLX announced the receipt of FDA 510(k) clearance for its Quantra 2.2 Breast Density Assessment Software. This software helps clinicians provide women with consistent ...

    43.46+0.50 (+1.15%)

    at Fri, Dec 15, 2017, 2:54PM EST - U.S. Markets close in 1 hr 6 mins

    Nasdaq Real Time Price

    • Open 43.40
    • High 43.64
    • Low 42.67
    • Prev. Close 42.96
    • 52 Wk. High 46.80
    • 52 Wk. Low 35.76
    • P/E 16.46
    • Mkt. Cap 11.98B
  4. Hologic, Inc. HOLX has continued to make a series of strategic developments within its core Breast Health business that contributes to approximately 40% to the company’s overall ...

  5. LONDON, UK / ACCESSWIRE / November 28, 2017 / Active-Investors issued a free report on Hologic, Inc. (NASDAQ: HOLX), which is readily accessible upon registration at www.active-investors.com ...

  6. Hologic Banks on Molecular Diagnostics, Competition Rife

    Zacks via Yahoo FinanceDec 07 13:07 PM

    On Dec 5, we issued an updated research report on Hologic, Inc. HOLX. The stock currently carries a Zacks Rank #3 (Hold). In the past three months, this manufacturer of mammography ...

  7. MARLBOROUGH, Mass., Nov. 26, 2017 /PRNewswire/ -- Hologic, Inc. (HOLX) announced today that it has signed a development and distribution agreement with Clarius Mobile Health for ...

  8. Hologic, Inc.HOLX announced the receipt of 510(k) clearance from the FDA for its Panther Fusion AdV/hMPV/RV assay. This is a multiplex assay that runs on the new Panther Fusion ...

  9. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$1.01. The estimated EPS forecast for the next fiscal year is -$3.44 and is expected to report on January 24th, 2018.

  10. "Clearance and launch of the new Fusion AdV/hMPV/RV assay completes our initial set of modular assays for respiratory viruses," said Tom West, president of the Diagnostic Solutions division ...

  11. Hologic: Meet Goldman Sach's New 'Conviction Buy'

    Benzinga via Yahoo FinanceDec 08 16:56 PM

    Goldman analyst Isaac Ro has a Buy rating on Hologic and raised the price target from $45 to $50. The favorable setup into fiscal 2018 positions Hologic to outperform, especially ...

  1. Ads
    related to Hologic, Inc